Frank Morich's most recent trade in Cue Biopharma Inc was a trade of 24,400 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Frank Morich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Frank Morich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Frank Morich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Frank Morich | Director | Purchase of securities on an exchange or from another person at price $ 3.75 per share. | 27 May 2022 | 28,000 | 28,000 (0%) | 0% | 3.8 | 105,000 | Common Stock |
| Cue Biopharma Inc | Frank Morich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Frank Morich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |